RUNX3 and colorectal cancer: In order to examine RUNX3 expression levels and DNA methylation status in colorectal cancer tissues, the use of quantitative methylation-specific polymerase chain reaction (QMSP) analysis and real-time PCR identified hypermethylation of RUNX3 in 70 of 105 colorectal carcinomas (66.7%).